Site-directed mutagenesis of the human adenosine A2A receptor. Critical involvement of Glu13 in agonist recognition

scientific article published on August 1996

Site-directed mutagenesis of the human adenosine A2A receptor. Critical involvement of Glu13 in agonist recognition is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0014-2999(96)00495-5
P932PMC publication ID5472059
P698PubMed publication ID8884226

P50authorKenneth A. JacobsonQ37387267
Adriaan P IJzermanQ40222626
P2093author name stringJ Kim
Q Jiang
J K Von Frijtag Drabbe Künzel
P2860cites workThe probable arrangement of the helices in G protein-coupled receptors.Q40872681
Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in nonreciprocal disruption of alpha 2-adrenergic receptor-G-protein interactions. A negative charge at amino acid residue 79 forecasts alpha 2A-adrenergic rQ41428196
D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary cultureQ42507079
Receptor binding profiles of amiloride analogues provide no evidence for a link between receptors and the Na+/H+ exchanger, but indicate a common structure on receptor proteinsQ43600354
Projection structure of rhodopsinQ59098567
Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptorQ63916823
Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranesQ72827364
Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptorQ24612312
Molecular characterization of a human brain adenosine A2 receptorQ28212728
Iodine-125-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptorsQ30462475
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potentialQ36332205
P433issue2-3
P407language of work or nameEnglishQ1860
P304page(s)269-272
P577publication date1996-08-01
P1433published inEuropean Journal of PharmacologyQ1376712
P1476titleSite-directed mutagenesis of the human adenosine A2A receptor. Critical involvement of Glu13 in agonist recognition
P478volume310

Reverse relations

cites work (P2860)
Q442473092- and 8-alkynyladenosines: conformational studies and docking to human adenosine A3 receptor can explain their different biological behavior
Q40452318A "locked-on," constitutively active mutant of the adenosine A1 receptor.
Q39424469A novel nonribose agonist, LUF5834, engages residues that are distinct from those of adenosine-like ligands to activate the adenosine A(2a) receptor.
Q28283019A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists
Q91406530A3 adenosine receptor activation mechanisms: molecular dynamics analysis of inactive, active, and fully active states
Q35602688Adenosine receptor agonists: from basic medicinal chemistry to clinical development
Q37724968Adenosine receptor modeling: what does the A2A crystal structure tell us?
Q63916757Allosteric modulation of A2A adenosine receptors by amiloride analogues and sodium ions
Q36172721Allosteric modulation of the adenosine family of receptors
Q37724971Allosteric modulators for adenosine receptors: an alternative to the orthosteric ligands.
Q30376612Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure.
Q43276048Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the beta2-adrenergic receptor and the human adenosine A2A receptor
Q42536494Identification of the adenine binding site of the human A1 adenosine receptor
Q44636374Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists
Q61785701Molecular Dynamics Simulations Reveal Insights into Key Structural Elements of Adenosine Receptors
Q92135187Molecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends
Q46581709Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies
Q36816987Molecular modeling of adenosine receptors: new results and trends.
Q36253713Mutagenesis Reveals Structure−Activity Parallels between Human A2AAdenosine Receptors and Biogenic Amine G Protein-Coupled Receptors
Q28364092Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides
Q90916644Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia
Q44784457Novel approaches for modeling of the A1 adenosine receptor and its agonist binding site
Q51034650Perturbation of fluid dynamics properties of water molecules during G protein-coupled receptor-ligand recognition: the human A2A adenosine receptor as a key study
Q33292715Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we?
Q31421740Site-directed mutagenesis studies of human A(2A) adenosine receptors: involvement of glu(13) and his(278) in ligand binding and sodium modulation
Q47333337Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms
Q37769342Structural features of adenosine receptors: from crystal to function.
Q38686607The Adenosinergic System as a Therapeutic Target in the Vasculature: New Ligands and Challenges.
Q37876534The structure of the adenosine receptors: implications for drug discovery.
Q43510634Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosine.

Search more.